Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

The India Fund, Inc. (IFN)

17.9   0.41 (2.34%) 05-18 02:12
Open: 17.8 Pre. Close: 17.49
High: 17.93 Low: 17.68
Volume: 103,202 Market Cap: 489(M)
The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.96 - 18.03 18.03 - 18.1
Low: 17.5 - 17.58 17.58 - 17.65
Close: 17.78 - 17.91 17.91 - 18.04

Technical analysis

as of: 2022-05-17 4:47:52 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 21.42     One year: 22.76
Support: Support1: 16.48    Support2: 13.71
Resistance: Resistance1: 18.34    Resistance2: 19.48
Pivot: 17.62
Moving Average: MA(5): 17.16     MA(20): 17.87
MA(100): 19.67     MA(250): 21.34
MACD: MACD(12,26): -0.5     Signal(9): -0.6
Stochastic oscillator: %K(14,3): 48     %D(3): 28.7
RSI: RSI(14): 47.7
52-week: High: 23.78  Low: 16.48
Average Vol(K): 3-Month: 118 (K)  10-Days: 133 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IFN ] has closed below upper band by 38.8%. Bollinger Bands are 29.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 17 May 2022
Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 genes - News-Medical.Net

Tue, 17 May 2022
Camelid IFNs could play important role in combating emerging zoonotic pathogens - News-Medical.Net

Tue, 17 May 2022
Type-I interferon stops immune system 'going rogue' during viral infections - Science Daily

Tue, 17 May 2022
Lymph node colonization and metastasis - Science

Tue, 17 May 2022
Inhaled Interferon Fails in Pivotal COVID Trial, but Developer Pushes On - Medpage Today

Mon, 16 May 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies -

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Financial Services
Industry:  Asset Management
Shares Out. 0 (M)
Shares Float 27 (M)
% Held by Insiders 0 (%)
% Held by Institutions 0 (%)
Shares Short 21 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 3
Operating Margin (%) 164
Return on Assets (ttm) -17.2
Return on Equity (ttm) -0.2
Qtrly Rev. Growth 6.84e+006
Gross Profit (p.s.) 17.46
Sales Per Share 49.11
EBITDA (p.s.) 8.20253e+006
Qtrly Earnings Growth 8
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0.36
Price to Cash Flow 0.59

Stock Dividends

Dividend 0
Forward Dividend 16940
Dividend Yield 0%
Dividend Pay Date 2019-01-09
Ex-Dividend Date 2021-12-28
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.